Javascript must be enabled to continue!
Comparison of HRCT Findings in Interstitial Lung Disease among Diabetic and Non-Diabetic Patients
View through CrossRef
Background: Diabetes mellitus (DM) is a chronic metabolic disease and its prevalence has been steadily increasing all over the world. DM and its associated micro and macrovascular complications result in significant morbidity and mortality. The microvascular complications are usually manifested as retinopathy, neuropathy, nephropathy and macrovascular complications generally affect the cardiovascular system. In addition to these complications, DM also affects the lungs because of its rich vascularity and abundance in connective tissue (collagen and elastin). DM has been found to cause microvascular complications and proliferation of extracellular connective tissue in the lungs, leading to decline in lung function in a restrictive pattern of Interstitial lung disease (ILD).Objective: To compare HRCT patterns and severity of interstitial lung diseases in diabetic and non-diabetic patients.Methods: A comparative cross-sectional study was conducted on patients diagnosed with interstitial lung disease, dividing them into diabetic and non-diabetic groups. All participants underwent High-Resolution Computed Tomography (HRCT) of the chest, and radiological patterns such as ground-glass opacities, reticulation, and honeycombing were systematically evaluated. The HRCT findings were then compared between both groups to assess the influence of diabetes mellitus on the pattern and severity of interstitial lung disease.Results: Furthermore, these findings are consistent with earlier research suggesting that radiological patterns in interstitial lung disease (ILD) are more closely related to disease-specific pathophysiological mechanisms rather than systemic metabolic conditions such as diabetes. Although some studies have reported reduced lung volumes and diffusing capacity in diabetic individuals, these functional impairments may not necessarily correspond to detectable structural abnormalities on imaging. In the present study, no statistically significant association was observed between diabetes and HRCT patterns of ILD. This lack of significance may be partly explained by unassessed variables that could influence pulmonary involvement, including the duration of diabetes, level of glycemic control, presence of diabetic complications, and medication use. The heterogeneity within the diabetic group may therefore have contributed to the absence of a significant correlation.Conclusion: The study shows that diabetic and non-diabetic patients were demographically comparable, with no significant variation in ground-glass opacities, nodules, consolidation, reticulations, or other radiological features. Fibrotic, cystic, inflammatory, and atelectatic changes, as well as honeycombing and usual interstitial pneumonia patterns, were similarly distributed in both groups. The extent of lung involvement and prevalence of bronchiectasis were also alike.
Knowledge Creation and Dissemination Centre
Title: Comparison of HRCT Findings in Interstitial Lung Disease among Diabetic and Non-Diabetic Patients
Description:
Background: Diabetes mellitus (DM) is a chronic metabolic disease and its prevalence has been steadily increasing all over the world.
DM and its associated micro and macrovascular complications result in significant morbidity and mortality.
The microvascular complications are usually manifested as retinopathy, neuropathy, nephropathy and macrovascular complications generally affect the cardiovascular system.
In addition to these complications, DM also affects the lungs because of its rich vascularity and abundance in connective tissue (collagen and elastin).
DM has been found to cause microvascular complications and proliferation of extracellular connective tissue in the lungs, leading to decline in lung function in a restrictive pattern of Interstitial lung disease (ILD).
Objective: To compare HRCT patterns and severity of interstitial lung diseases in diabetic and non-diabetic patients.
Methods: A comparative cross-sectional study was conducted on patients diagnosed with interstitial lung disease, dividing them into diabetic and non-diabetic groups.
All participants underwent High-Resolution Computed Tomography (HRCT) of the chest, and radiological patterns such as ground-glass opacities, reticulation, and honeycombing were systematically evaluated.
The HRCT findings were then compared between both groups to assess the influence of diabetes mellitus on the pattern and severity of interstitial lung disease.
Results: Furthermore, these findings are consistent with earlier research suggesting that radiological patterns in interstitial lung disease (ILD) are more closely related to disease-specific pathophysiological mechanisms rather than systemic metabolic conditions such as diabetes.
Although some studies have reported reduced lung volumes and diffusing capacity in diabetic individuals, these functional impairments may not necessarily correspond to detectable structural abnormalities on imaging.
In the present study, no statistically significant association was observed between diabetes and HRCT patterns of ILD.
This lack of significance may be partly explained by unassessed variables that could influence pulmonary involvement, including the duration of diabetes, level of glycemic control, presence of diabetic complications, and medication use.
The heterogeneity within the diabetic group may therefore have contributed to the absence of a significant correlation.
Conclusion: The study shows that diabetic and non-diabetic patients were demographically comparable, with no significant variation in ground-glass opacities, nodules, consolidation, reticulations, or other radiological features.
Fibrotic, cystic, inflammatory, and atelectatic changes, as well as honeycombing and usual interstitial pneumonia patterns, were similarly distributed in both groups.
The extent of lung involvement and prevalence of bronchiectasis were also alike.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
<b>Identification of Interstitial Lung Diseases in Smokers vs Non-Smokers Using HRCT</b>
<b>Identification of Interstitial Lung Diseases in Smokers vs Non-Smokers Using HRCT</b>
Background: Interstitial lung diseases (ILDs) are a diverse group of pulmonary disorders characterized by inflammation and fibrosis of the lung interstitium, often leading to irrev...
HRCT imaging features of systemic sclerosis-associated interstitial lung disease
HRCT imaging features of systemic sclerosis-associated interstitial lung disease
Background: The aim of the study was to evaluate radiographic features of systemic sclerosis-associated interstitial lung disease. Patients and methods: 116 patients with systemic...
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v1
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v1
Interstitial lung disease is a heterogeneous group of disorders. Chest high-resolution computed tomography is considered the "gold" standard radiological method for diagnosis of IL...
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v1
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v1
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases Interstitial lung disease is...
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v2
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v2
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases Interstitial lung disease is...
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v3
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases v3
The correlation between the transthoracic lung ultrasound score (LUS) and the severity of changes in HRCTon patients with interstitial lung diseases Interstitial lung disease is...

